Dermatology News and Research

Latest Dermatology News and Research

Lyfebulb, Immune collaborate to increase awareness of bullous pemphigoid

Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc., announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties.

24 Jul 2014

Caffeine intake may aggravate hot flashes and night sweats in postmenopausal women

A new Mayo Clinic study, published online today by the journal Menopause, found an association between caffeine intake and more bothersome hot flashes and night sweats in postmenopausal women.

24 Jul 2014

BP variability may be ‘CV risk integrator’

Increased variability in blood pressure may be an indicator of overall cardiovascular risk rather than being a risk factor per se, suggest researchers.

21 Jul 2014

Early-career physicians receive National Psoriasis Foundation fellowship to study psoriasis

Twelve residents and medical students each received a one-year, $50,000 National Psoriasis Foundation fellowship to study psoriasis.

21 Jul 2014

13 researchers awarded National Psoriasis Foundation fellowship to study psoriasis

Twelve residents and medical students each received a one-year, $50,000 National Psoriasis Foundation fellowship to study psoriasis. The fellowships aim to increase the number of scientists studying and treating psoriatic disease by encouraging promising doctors to dedicate their careers to the study of psoriasis as physician researchers.

18 Jul 2014

Doctors still prescribe patience as part of acne treatment regimen

When it comes to treating acne, much has advanced medical practice, but patients are still prescribed patience as part of any treatment regimen, according to a nationally recognized expert on the skin condition that affects millions of teenagers in the U.S. each year.

18 Jul 2014

Glenmark plans to set up new manufacturing facility at Monroe Corporate Center, USA

Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the US.

17 Jul 2014

Study attempts to link sun exposure and low vitamin D levels with increased death rate

Recently, a study in the Journal of Internal Medicine suggested that women who avoid sun exposure are twice as likely to die as compared to those who receive sun exposure.

17 Jul 2014

Encapsula releases 2 new liposome based products

Encapsula NanoSciences announces the release of two new liposome based products; Curcusome® and Taurosome™. Curcusome® or liposomal curcumin is a nutraceutical supplement that comes innovatively packaged in a powder release cap for consumer ease.

17 Jul 2014

Phase III research shows that new drug improves symptoms related to plaque psoriasis

Randomized, phase III research from the University of Alabama at Birmingham shows that a new drug improves symptoms related to moderate to severe plaque psoriasis, a chronic skin disease of scaling and inflammation.

17 Jul 2014

Thirteen scientists receive grant to identify new treatments, cure for psoriasis

Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis—an autoimmune disease that appears on the skin, affecting 7.5 million Americans—and psoriatic arthritis—an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis.

16 Jul 2014

Virobay announces closing of expanded Series B second tranche financing

Virobay, Inc., a clinical stage pharmaceutical company with a platform of cathepsin protease inhibitors being developed for the treatment of neuropathic pain, autoimmune disease and fibrosis, today announced the closing of an expanded Series B second tranche financing of $8.0 million.

16 Jul 2014

Healthy lifestyle helps hard-to-treat hypertensive patients

Maintaining a healthy lifestyle can prevent cardiovascular events even among patients with apparent treatment-resistant hypertension, say researchers.

15 Jul 2014

Night-time BP variability improves vascular risk prediction

Measuring night-time variability in the blood pressure of patients with hypertension may help to predict their risk of having a cardiovascular event, show data from an international study.

15 Jul 2014

Metvix PDT now available at Odette Cancer Centre as additional treatment option for NMSC patients

The Odette Cancer Centre at Sunnybrook Health Sciences Centre in conjunction with Galderma Canada are pleased to announce that Metvix PDT (Photodynamic Therapy), is now available at the Odette Cancer Centre in Toronto as an additional treatment option for patients with NMSC (non-melanoma skin cancer).

15 Jul 2014

Twitter should be better utilized to convey public health messages, say researchers

Twitter and other social media should be better utilized to convey public health messages, especially to young adults, according to a new analysis by researchers at UC San Francisco.

14 Jul 2014

Doctor creates TULA skincare line using Probiotic Technology

TULA (tulaforlife.com), the new skin care line using a patented Probiotic Technology, today announced the launch of their first selection of skin care products.

11 Jul 2014

New diagnostic procedure helps differentiate psoriasis from eczema

In some patients, the chronic inflammatory skin diseases psoriasis* and eczema** are similar in appearance. Up to now, dermatologists have therefore had to base their decision on which treatment should be selected on their own experience and an examination of tissue samples.

10 Jul 2014

YouTube allows researchers to connect directly with public on topics of skin cancer

YouTube is for more than watching World Cup highlights, Brian Williams refreshing old school rap classics, and videos of skateboarders landing in unfortunate positions on railings.

10 Jul 2014

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in moderate-to-severe AD

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema.

10 Jul 2014

Dermatology News and Research

Latest Dermatology News and Research

Lyfebulb, Immune collaborate to increase awareness of bullous pemphigoid

Caffeine intake may aggravate hot flashes and night sweats in postmenopausal women

BP variability may be ‘CV risk integrator’

Early-career physicians receive National Psoriasis Foundation fellowship to study psoriasis

13 researchers awarded National Psoriasis Foundation fellowship to study psoriasis

Doctors still prescribe patience as part of acne treatment regimen

Glenmark plans to set up new manufacturing facility at Monroe Corporate Center, USA

Study attempts to link sun exposure and low vitamin D levels with increased death rate

Encapsula releases 2 new liposome based products

Phase III research shows that new drug improves symptoms related to plaque psoriasis

Thirteen scientists receive grant to identify new treatments, cure for psoriasis

Virobay announces closing of expanded Series B second tranche financing

Healthy lifestyle helps hard-to-treat hypertensive patients

Night-time BP variability improves vascular risk prediction

Metvix PDT now available at Odette Cancer Centre as additional treatment option for NMSC patients

Twitter should be better utilized to convey public health messages, say researchers

Doctor creates TULA skincare line using Probiotic Technology

New diagnostic procedure helps differentiate psoriasis from eczema

YouTube allows researchers to connect directly with public on topics of skin cancer

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in moderate-to-severe AD

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dermatology News and Research

Latest Dermatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in